Science Explorer Back to mapMap
Discussion
Researcher · BioNTech (Germany) · Germany

Azita J. Mahiny

Azita J. Mahiny publishes mostly in Molecular Biology, Immunology and Infectious Diseases, on topics such as RNA Interference and Gene Delivery, Virus-based gene therapy research and Immunotherapy and Immune Responses.

ORCID 0000-0001-9331-5869 OpenAlex
World rank
#998,577
of 7,710,434 ranked researchers
Rank in Germany
#49,225
of 364,343
Works
17
Citations
2.7k
Citations per work
156.3
h-index
11
i10-index 12Top 71% in Molecular Biology
Azita J. Mahiny

What does Azita J. Mahiny research?

Azita J. Mahiny's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Immunology and Microbiology (26%), Medicine (17%).

Life Sciences: 11 works · 63.8% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 38.3% of their workMolecular Biology: 5 works · 29.8% of their workGenetics: 1 works · 8.5% of their workImmunology and Microbiology: 4 works · 25.5% of their workImmunology: 4 works · 25.5% of their workEverything else: 3 works · 19.1% of their workHealth Sciences: 3 works · 17.1% of their workMedicine: 3 works · 17.1% of their workInfectious Diseases: 1 works · 8.5% of their workOncology: 1 works · 4.3% of their workPulmonary and Respiratory Medicine: 1 works · 4.3% of their workTHEIR WORKAzita J. Mahiny17works
Life Sciences64%Health Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology738.3%
    2. Immunology and Microbiology425.5%
  2. Everything else319.1%
    1. Medicine317.1%
  1. 1Molecular Biology30% of their works
  2. 2Immunology26% of their works
  3. 3Infectious Diseases8% of their works
  4. 4Genetics8% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Azita J. Mahiny's research?

The keywords of their largest research topics: Gene Therapy, Immunity, RNA Interference, siRNA Delivery, AAV, Cancer Immunotherapy, Coronavirus and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Gene Therapy112 topics
  2. Immunity72 topics
  3. RNA Interference71 topic
  4. siRNA Delivery71 topic
  5. AAV41 topic
  6. Cancer Immunotherapy41 topic
  7. Coronavirus42 topics
  8. Dendritic Cells41 topic
  9. Vaccine42 topics
  10. Viral Vectors41 topic
  11. Foxp331 topic
  12. Genome Engineering31 topic
  13. NK Cell Recognition31 topic
  14. Natural Killer Cells31 topic
  15. RNA-Guided31 topic
  16. SARS-CoV-231 topic
  17. TGF-ß31 topic
  18. spike protein31 topic
  19. Circovirus11 topic
  20. Porcine Reproductive and Respiratory Syndrome Virus11 topic

Where does Azita J. Mahiny work?

Azita J. Mahiny's main affiliation in the publication record is BioNTech (Germany), Germany.

How many publications and citations does Azita J. Mahiny have?

OpenAlex counts 17 works and 2,657 citations for Azita J. Mahiny, an h-index of 11, ranking #998,577 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Azita J. Mahiny. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.